Sex differences in response to the endothelin receptor antagonist atrasentan in individuals with type 2 diabetes and chronic kidney disease: a post hoc analysis of the SONAR trialJ. David Smeijer, Hiddo J.L. Heerspink|Diabetologia|2024Cited by 3